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Abstract
In family-based data, association information can be partitioned into the between-family information and the within-family
information. Based on this observation, Steen et al. (Nature Genetics. 2005, 683–691) proposed an interesting two-stage test
for genome-wide association (GWA) studies under family-based designs which performs genomic screening and replication
using the same data set. In the first stage, a screening test based on the between-family information is used to select
markers. In the second stage, an association test based on the within-family information is used to test association at the
selected markers. However, we learn from the results of case-control studies (Skol et al. Nature Genetics. 2006, 209–213) that
this two-stage approach may be not optimal. In this article, we propose a novel two-stage joint analysis for GWA studies
under family-based designs. For this joint analysis, we first propose a new screening test that is based on the between-
family information and is robust to population stratification. This new screening test is used in the first stage to select
markers. Then, a joint test that combines the between-family information and within-family information is used in the
second stage to test association at the selected markers. By extensive simulation studies, we demonstrate that the joint
analysis always results in increased power to detect genetic association and is robust to population stratification.
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Introduction
Currently, the family-based association tests such as the TDT
and its extensions [1–6] are still the most commonly used methods
to detect disease susceptibility loci in family-based GWA studies.
This kind of methods uses the within-family information, but not
the between-family information. The reason is that methods used
between-family information may be subject to bias caused by
population stratification. Recently, based on the observation that
the association information in the family sample can be split into
the between-family component and the within-family component,
Steen et al. [7] proposed a two-stage test for family-based GWA
studies. We call this method Family-based Two-Stage Approach
(FTSA). In the first stage of FTSA, a test based on between-family
information is used to screen markers, that is, choose R ‘‘top’’
markers. In the second stage of FTSA, a family-based association
test based on within-family information is used to test the R
selected markers for association. FTSA is robust to population
stratification because the association is determined by the family-
based association test in the second stage. Furthermore, since the
statistic used in the first stage is statistically independent of that in
the second stage, the overall significance level of the algorithm
does not need to be adjusted for the first stage. In the following
discussion, we call the tests used in the first stage and in the second
stage screening test and association test, respectively.
In case-control studies, several authors have proposed a two-
stage design which utilizes two independent samples [8,9]. The
first stage that uses the first sample is to screen and select SNPs
for association tests. In the second stage, the association tests are
conducted on the selected SNPs by using the second sample, so
that the number of association tests is diminished and the
correction for multiple testing is less severe. Recently, Skol et al.
[10] pointed out that joint analysis in which the test used in the
second stage is the combination of the two tests based on the two
samples is more powerful than replication-based analysis in
which the test used in the second stage is based on the second
sample only. There are some similarities between FTSA and the
two-stage approach in case-control studies. Can we do joint
analysis in FTSA as Skol et al. [10] did for the two-stage
approach in case-control studies. One problem hindering us
from doing joint analysis in FTSA is that the screening test in
FTSA can be susceptible to population stratification and thus the
joint test in joint analysis that combines the screening test and
association test can be also susceptible to population stratifica-
tion. To overcome this problem, we borrow ideas from methods
for case-control studies to construct a screening test that is based
on between-family information and also robust to population
stratification.
In case-control studies, it has been long recognized that
population stratification can seriously confound association
results [11,12]. To overcome this problem, several methods that
use a set of unlinked genetic markers, also called genomic
markers, genotyped in the same samples have been developed to
control for population stratification. These methods can be
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(GC) approach that adjusts the ordinary chi-square test statistic,
X
2.T o ,X
2 =l and assumes X
2 =l to follow a chi-square
distribution, where l can be estimated using genotypes at
genomic markers [13–15]. The second is ‘‘structured associa-
tion’’ (SA) that uses a set of independent genetic markers to
estimate the number of subpopulations and the ancestry
probabilities of individuals from putative ‘‘unstructured’’ sub-
populations. This information is then used to test for association
[16–19]. The third group is principal components (PC) approach
that summarizes the genetic background through the PC analysis
of genotypes at genomic markers [20–24]. The PCs calculated
from a matrix of genotypes at genomic markers can be further
used to eliminate the effect resulting from population stratifica-
tion. Zhang et al. [20] and Chen et al. [21] modeled the
relationship between trait values, genotype at the candidate
marker, and PCs through a semi-parametric model, where the
trait value is treated as the dependent variable. Recently, Price
et al. [23] presented a linear regression method by regressing
both the trait value and genotype at the candidate marker on the
PCs. Association between the trait and candidate marker is then
tested with the residual correlation. The PC approach is much
simpler and computationally faster than the SA approach and is
more powerful than the GC approach. The fourth is the mixed
linear model (MLM) approach [25,26] that corrects for a wide
range of sample structures by explicitly accounting for pairwise
relatedness between individuals.
In this article, we propose a novel approach to do joint
analysis within the framework of FTSA. We first perform PC
analysis based on parental genotypes at a set of genomic
markers and then use a PC approach to eliminate any effect of
population stratification both in genotypes at the candidate
marker and trait values for all family members. A screening
test is then constructed based on adjusted between-family
information and parental trait values. We use this screening
test which is robust to population stratification to select
markers in the first stage. In the second stage, we do joint
a n a l y s i si . e .u s eat e s tt h a ti sac o m b i n a t i o no ft h es c r e e n i n gt e s t
and the association test to test association at the selected
markers. The joint analysis is robust to population stratifica-
t i o nb e c a u s eb o t ht h es c r e e n i n gt e s tu s e da tt h ef i r s ts t a g ea n d
the joint test used at the second stage are robust to population
s t r a t i f i c a t i o n .W ee v a l u a t et h ep e r f o r m a n c eo fo u rj o i n t
analysis approach by simulation studies under a variety of
population admixture models. Our simulation studies show
that the proposed joint analysis approach is robust to
population stratification and is consistently more powerful
than FTSA proposed by Steen et al. [7].
Methods
Consider a GWA study of n nuclear families with ni. children in
the i
th. Family i~1,2,...,n ðÞ and L markers have been genotyped
for each sampled individual. For the i
th. family, we use yik. and
xik. to denote the trait values and genotypic scores at the candidate
locus of the, k
th. member in the i
th. family (K=1and 2 for the two
parents), where genotypic score is the number of copies of minor
allele.
Screening Test
We assume that the parental phenotypes are available. In this
case, by incorporating parental phenotypes, Feng et al. [27]
proposed a screening test statistic
Tscreen Sn
i~1 Ui =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sn
i~1 U
2
i
q
, ð1Þ
Where Ui~(xi{x)(yi{y)zS2
k~1 (xik{x)(yik{y);xi~ 1
2 xi1 ð
zxi2Þ;yi~ 1
ni S
ni z2
k~3 yik; x and y are the overall means of
genotypic scores and trait values, respectively. Feng et al. [27]
have shown that this test is more powerful than one not
incorporating parental phenotypes and is independent of family-
based association tests based on within-family information.
However, this test may be subject to bias caused by population
stratification and thus cannot do joint analysis by combining
Tscreen. with the test statistic of a family-based association test
because the combined test may be also subject to bias caused by
population stratification. We previously suggested using the PCs of
genotypes at genomic markers to represent the genetic background
of unrelated individuals and using the genetic background to
control for population stratification in population-based associa-
tion studies [20–22]. We will use this idea to construct a test based
on between-family information and incorporating parental
phenotypes such that this test is robust to population stratification.
To construct the test, we first randomly choose l markers from the
L markers in GWA panel as genomic markers. For the i
th family,
let Xik ~ Xik1,...,xikl
T ðÞ denote multiple marker genotypic
scores at the l randomly chosen markers of the k
th. member in
the i
th. family (k=1and 2 for the two parents). We perform a PC
analysis to summarize the genotype data at genomic markers.
Because our data are family data, a naive PC analysis with all
available data will result in biased directions of maximum
variability for the data. Thus, the PC analysis is applied to only
the parents in each family.
Let S~Sn
i~1 S2
k~1 Xik{X
  
Xik{X
   T denote the variance-
covariance matrix of the genotype data for all of the 2n parents,
where, X. is the overall mean of parental genotypic scores. Let ej
be the jth eigenvector corresponding to the jth largest eigenvalue of
S for j~1,   ,l. Then, the jth. PC for the k
th member of the i
th
family is given by tijk ~eT
j Xik{X
  
Here we consider only the
first K PCs (in this study, we use K=10). Because the PCs represent
the genetic background information, we adjust both the trait and
genotype at candidate loci for this genetic background information
by applying linear regression [23]. That is,
yik ~b0 zb1 ti1k z   zbK tiKk zeik
and
xik ~ak0 zak1 ti1k z   zakK tiKk ztik,
where eik and tik are random errors for i~1,...,n and k=1,2. Let
b b b0 ,b b b1 ,...,b b bK and b a ak0,b a a k1,...,akK be the least square estima-
tors of b b b0 ,b b b1 ,...,b b bK and, ak0 ,ak1 ,...,akK , respectively. The
residuals of the trait values and genotypic scores at the candidate
locus for parents and children of the i
th. family are calculated by
y 
ik ~yik {b b b0 {b b b1 ti1k {   {b b bK tiKk
and
x 
ik ~xik {b a a k0 { b a ak1 ti1k {   {b a a kK tiKk ,
where i~1,...,n and k~1,2,...,ni z2. We can consider y 
ik
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ik as the trait value and genotypic score of the k
th. member
in the, i
th. family after adjusted for population stratification.
Based on the adjusted trait values and genotypic scores, we
propose the following screening test, called admixture screening
(Ascreen) test,
TAscreen ~Sn
i~1 Ui =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sn
i~1 U
2
i
q
ð2Þ
where Ui ~ x 
i {x    
y 
i {y    
zS2
k~1 x 
ik {x    
y 
ik {y    
;
x 
i ~ 1
2 x 
i1 zx 
i2
  
;y 
i ~ 1
ni S
ni z2
k~3 y 
ik;x  and y .are the overall
means of genotypic scores and trait values after adjusted for
population stratification, respectively. Under the null hypothesis,
TAscreen follows a standard normal distribution.
Association Test
We use quantitative pedigree transmission disequilibrium
(QPTD) as our family-based association test [28]. Using the
notation given above, the association test statistic is given by
Ta ~Sn
i~1 Vi =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sn
i~1 V
2
i
q
, ð3Þ
where Vi ~ 1
ni Sniz2
k~3 xik {x ðÞ yik {y ðÞ Under the null hypothesis
of no association, Ta. asymptotically follows the standard normal
distribution.
Joint Analysis
In the first stage, we select R markers with the smallest p-values
of the admixture screening test. This selection means that there is a
constant C such that a marker is selected if Tscreen jj wC. In the
joint analysis, a new test statistic
Tjoint ~TAscreen zTa ð4Þ
is used to test association in the second stage. Let tjoint. be the
observed value of the statistic Tjoint., Then, in the second stage, the
p-value of the test Tjoint. is given by
Pjoint ~Pr jTjoint jwjtjointjjjTAscreen jwC
  
:
Let C2~ tjoint
        and T denote the event of TAscreen jj wC. Similarly
to equation (2) in Skol et al. [10], we have
Pjoint~Pr Tjoint
       wC2jT
  
~
ð {c
{?
PT jointwC2jTAscreen~x
    
zPT jointv{C2jTAscreen~x
    
fx jT ðÞ dx
z
ð ?
C
PT jointwC2jTAscreen~x
    
zPT jointv{C2jTAscreen~x
    
fx jT ðÞ dx
~
ð {c
{?
1{W C2{x ðÞ zW {C2{x ðÞ ½  fx jT ðÞ dx
z
ð ?
c
1{W C2{x ðÞ zW {C2{x ðÞ ½  fx jT ðÞ dx,
where W is the cumulative distribution function of the standard
normal distribution; fx jT ðÞ is the probability density function of
TAscreen given that TAsreen jj wC i:e: fx jT ðÞ ~
q(x)
21 {W C ðÞ ðÞ
if jxjwC and jxjwC otherwise; w x ðÞis the probability density
function of the standard normal distribution. Thus, the p-value
Pjoint can be calculated numerically. In summary, for the joint
analysis, we first select R top markers using the admixture
screening test TAscreen and then test association for each of the R
selected markers using the joint test Tjoint. For one of the R
selected markers, we declare that this marker is significant at level
a if the p-value of the joint test Pjoint is less than a=R.
Methods Compared
We compare the proposed joint analysis method with two
other methods that is described below. One is FTSA
proposed by Steen et al [7]. In FTSA, the screening test
does not adjust for population stratification. In this study,
we use Tscreen given in equation (1) as the screening test of
FTSA. In the first stage of FTSA, R markers with the
smallest p-values of the screening test Tscreen are selected. In
the second stage, the association test Ta given by equation
(4) is used to test each of the R selected markers. A marker
in the R selected markers is declared significant at level a if
the p-value of the association test Ta is less than a=R.T h e
other method we compare with is a method called
Admixture Family-based Two-stage Approach (AFTSA)
that is similar to FTSA but replaces the screening test
Tscreen in FTSA by the admixture screening test TAscreen
given by equation (2).
Results
We used simulation studies to compare the performance of the
joint analysis with FTSA and AFTSA. We also compared FTST
with AFTSA to see if adjusting population stratification in the
screening test can improve power of FTSA. The simulation setup
used in this study was similar to that of Zhu et al [29]. We
considered three sets of simulations: a homogeneous population, a
structured population which contained two subpopulations, and
an admixture population that mimicked African American
population.
Set 1: A Homogeneous Population
In this set of simulations, we simulated samples based on the
haplotype data of 120 European chromosomes (CEU) released by
the HapMap project [30]. However, we used only the haplotype
data on chromosome 1 at tagging SNPs. There are 34720 SNPs in
total. To generate the genotype of a parent, we generated two
haplotypes that are the recombinants of the 120 HapMap
chromosomes. To generate a recombinant of the 120 chromo-
somes, we first generated a number of crossovers across the
chromosome by a Poisson process with an average of 6 crossovers
per Morgan. The crossover locations were generated according to
a uniform distribution. The crossover locations divided the
chromosome into segments. Each segment of the recombinant
was a random chosen haplotype from the HapMap chromosomes
in the same segment. The offspring genotypes were generated by
randomly transmitting one of the two haplotypes of the father and
the mother with the crossovers occurring according to the genetic
map. The LD pattern across a chromosome was generally
preserved for the SNPs that are closely located.
To generate trait values under the null hypothesis, for a
nuclear family with m children, let Y1 ~ yF ,yM ðÞ and
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the m children. Assumed that Y1,Y2 ðÞ followed a normal
distribution with a mean vector of zero and variance-covariance
matrix of
S~
S11 S12
S21 S22
 !
, where S11 ~
10
01
 !
,
S12 ~ST
21 ~
r ... r
r     r
 !
, and S22 ~
1     0
. .
.
P . .
.
r     1
0
B B @
1
C C A
This covariance structure meant that the father and mother
were independent, and parents with children and children with
children were correlated with the correlation coefficient of r (in
this study, we use r=0.4). The conditional distribution of
Y2 ~ y1 ,y2 ,...,ym ðÞ given parental trait values, Y1 ~ yF ,yM ðÞ
was a normal distribution with mean vector of mc ~S21 S{1
11 Y1.
and variance-covariance matrix of Sc~S22{S21S{1
11 S12.T o
generate trait values of all individuals in the family, we first
generated the trait value of each parent by using a standard
normal distribution. The trait values of the children can be
generated by a normal distribution with a mean vector of mc and
variance-covariance matrix of Sc, given the trait values of their
parents.
Under the alternative hypothesis, we generated the trait values
of a nuclear family with B members from model
yb ~xb bzeb b~1,2,...,B ðÞ where xb. was the numerical code
of genotype g at the disease locus and
xb ~
0, if g~aa
1, if g~aA or AA0
(
xb
0, if g~aa or aA
1, if g~AA
(
,
and xb ~
0, if g~aa
1, if g~aA
2, if g~AA
8
> > <
> > :
for a dominant, recessive, and additive model, respectively (a and A
were the two alleles at the disease locus and A was the high risk
allele); b was a constant and e1,...,eB were background trait
values generated under the null hypothesis using aforementioned
method. The value of b was determined by heritability h and was
given by b~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
h
1{h ðÞ 2{p ðÞ 1{p ðÞ
2, b~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
h
1{h ðÞ p2 1{p2 ðÞ
q
,
r
, and
b~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
h
21 {h ðÞ p 1{p ðÞ
q
for a dominant, recessive, and additive model,
respectively, where p was the allele frequency of the high risk allele.
Set 2: A Structured Population with Two Subpopulations
In this set of simulations, we simulated samples using the
haplotype data of 120 European chromosomes (CEU) and 120
African chromosomes (YRI) released by the HapMap project [30].
In these simulations, we again used only the haplotype data on
chromosome 1 at the 34720 tagging SNPs. We considered that all
members of a family were from a same subpopulation. The
genotypes can be generated in the same way as that in the
simulation set 1. In this set of simulations, we sampled 70% of
families from European subpopulation and 30% of families from
African subpopulation. We generated the trait values of a nuclear
family with B members from model
yb ~m=5zxb b1 zeb b~1,2,...,B ðÞ
if this family was from European subpopulation and
yb ~xb b2 zeb b~1,2,...,B ðÞ
if this family was from African subpopulation, where e1,...,eB
were background trait values generated under the null hypothesis
in simulation set 1; xb was the numerical code of genotype at the
disease locus; m was a constant that measured the difference of the
average trait values between the two subpopulations; b1 and b2
can be determined by heritability h and the relationship was given
in simulation set 1. We used the same value of h in the two
subpopulations and thus b1 and b2 may be different due to the
difference of allele frequencies of the high risk allele in the two
subpopulations. Furthermore, we set h=0 and thus b1~b2~0 for
generating the trait values under the null hypothesis, and h.0 for
generating the trait values under the alternative hypothesis.
Set 3: An Admixture Population with Two Ancestral
Populations
Again, we simulated samples based on the chromosome 1 data
of 120 European chromosomes and 120 African chromosomes
released by the HapMap project [30]. We first generated
haplotype exchange points on the chromosome among the
populations by using a Poisson process, with an average of 6
crossovers per Morgan. This is equivalent to a population that has
been admixed for an average of 6 generations. In each region
between two exchange points, we determined which ancestral
population a haplotype came from based on a distribution of
admixture proportions of Africans and Europeans, which we set to
(0.8, 0.2). We then applied the same method as for simulation set 1
to generate a person’s genotypes from the selected ancestral
population. The method in simulation set 1 for generating
offspring genotypes was also applied.
We generated the trait values of a nuclear family with B
members from model yb~mlzxbb1zeb b~1,2,...,B ðÞ , where
e1,...,eB and xb were the same as in simulation set 2; lb was
European admixture proportion of the bth member in the family; m
and b were constants and b can be determined by heritability h.
Again, we set h=0for generating the trait values under the null
hypothesis, and h.0 for generating the trait values under the
alternative hypothesis.
In all of the three sets of simulations, we used 1000 replicated
samples to evaluate the type I error rates and power and
considered nuclear family with one child i.e. trio as the family
structure. To evaluate the type I error, we considered different
sample sizes, different number of markers used to control for
population stratification, and different values of m. However, we
fixed the value of R, the number of markers selected at the first
stage, as 10. We evaluated type I error rates of the three methods
(joint analysis, FSTA, and AFSTA) as well as two screening tests
Tscreen and TAscreen ðÞ . For evaluating type I error rates of the joint
analysis, FSTA, and AFSTA, we used 1,000 replicated samples
and thus the standard deviation for the type I error rates was ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:05|0:95=1000
p
&0:007 and the 95% confidence interval was
(0.036, 0.064) for the nominal level of 0.05. For evaluating type I
error rates of Tscreen and TAscreen although we still used 1,000
replicated samples, we performed 34720 tests for each sample
(equivalent to 16200 independent tests calculated using the
Joint Analysis for GWAS in Family-Based Designs
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I error rates was
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:05|0:95=1000=16200
p
&0:000054 and the
95% confidence interval was (4.989%, 5.011%) for the nominal
level of 5%.
Table 1, 2, 3 gave type I error rates of the five tests for
simulation set 1 to set 3, respectively. From the three tables, we
can see that type I error rates of the joint analysis, FSTA, and
AFSTA had the same pattern across simulation set 1 to set 3, i.e.
the three tests were slightly conservative. This conservative was
probably due to the fact that we used Bonferroni correction to
adjust for multiple testing in the second stage. Table 1, 2, 3 showed
that although Tscreen was a valid test in a homogeneous population
(Table 1), it would lead to false positive in structured populations
(Table 2, 3). Table 1, 2, 3 also showed that TAscreen was a valid test
in a homogeneous population (Table 1) and it was also a valid test
in structured populations if 800 or more genomic markers were
used to control for population stratification (Table 2, 3). The non-
inflated type I error rates of AFSTA also show that the admixture
screening test TAscreen used in the first stage and Ta used in the
second stage are independent. If TAscreen And Ta are correlated
(either positive or negative correlated), a marker with a small p-
value of TAscreen will have a high probability to have a small p-
value of Ta, and thus, AFSTA will have inflated type I error rates.
For power comparison, we considered different scenarios which
included different values of heritability h, different number of
markers selected at the first stage, different values of m, and
different sample sizes. To evaluate power, in each replication, we
randomly chosen a marker with minor allele frequency (calculated
from European subpopulation in simulation set 2) in the interval
(0.1, 0.3) as the disease locus and the minor allele as the high risk
allele for dominant and additive models while the major allele as
the high risk allele for recessive model. Results of power
comparison were summarized in Figure 1, 2, 3 for simulation set
1 to set 3, respectively. Under simulation set 1, which considered a
homogeneous population, the joint analysis was consistently more
powerful than FSTA and AFSTA. Also, FSTA and AFSTA had
Table 1. Type I error rates (in percentage) of the five tests based on simulation set 1.
Method
S L Joint FTSA AFTSA Tscreen TAscreen
400 200 3.3 4 3.7 4.99713 5.0091
400 3.8 2.8 3.1 4.99812 5.00628
800 2.7 3.5 3.6 4.98895 5.01246
600 200 3.5 3 3.4 4.99385 5.00721
400 3.3 3.3 3.7 4.98347 5.00162
800 3.2 3.7 3.8 4.98031 5.01397
800 200 3.5 4.1 5.3 4.99007 4.99439
400 4.4 4.4 5.0 4.99462 5.01143
800 2.9 3.8 3.8 4.99412 5.01168
Significant level is 5%.
Note: S denotes sample size in trios; L denotes the number of genomic markers used to control population stratification.
doi:10.1371/journal.pone.0021957.t001
Table 2. Type I error rates (in percentage) of the five tests based on simulation set 2.
m=1 m=2
S L Joint FTSA AFTSA Tscreen TAscreen Joint FTSA AFTSA Tscreen TAscreen.
400 200 3.7 3.3 4.2 69.9 5.41605 4.3 4.5 4.3 80.3 6.53089
400 3.4 4.2 4.9 69.9 5.15228 3.5 3.9 4.2 80.4 5.4674
800 4.1 2.8 4.6 69.9 5.00927 3.3 3.1 4.5 80.3 5.0182
600 200 3.6 2.9 3.3 75.3 5.5889 4.0 3.2 4.4 83.9 7.29293
400 3.9 3.8 3.1 75.3 5.18648 4.1 3.6 4.0 83.9 5.6435
800 3.4 4.4 4.5 75.3 5.00261 4.2 4.1 4.9 83.9 5.01144
800 200 3.5 3.9 3.6 78.5 5.77735 3.7 3.9 3.1 85.9 7.99526
400 4.5 4.6 4.6 78.4 5.20667 4.8 5.2 5.7 85.9 5.81495
800 3.7 3.2 3.8 78.4 5.01154 3.4 4.1 3.1 85.9 5.01228
Significant level is 5%.
Note: S denotes sample size in trios; L denotes the number of genomic markers used to control population stratification.
doi:10.1371/journal.pone.0021957.t002
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admixture screening test, robust to population stratification, did
not lose power when compared to the traditional screening test. In
simulation set 2, we considered a structured population with two
subpopulations. In this set of simulations, the joint analysis was
again consistently more powerful than the other two methods, and
AFSTA was consistently more powerful than FSTA, which
showed that using the admixture screening test instead of
traditional screening test increased power in the presence of
population stratification (Figure 2). In simulation set 3, we
considered an admixture population with two ancestral popula-
tions which also leaded to the problem of population stratification
but not as strong as that in simulation set 2. In this set of
simulations, the pattern of power comparison was very similar to
that in simulation set 2, but the power difference between FSTA
and AFSTA was not as large as that in simulation set 2 (Figure 3).
In summary, the joint analysis was consistently the most powerful
one among the three methods we considered. Comparing the
other two methods, AFSTA had almost identical power with
FSTA in the case of no population stratification and was more
powerful than FSTA in the presence of population stratification.
Discussion
In this article, we proposed a novel method to perform joint
analysis within the framework of the family-based two-stage
analysis. In the joint analysis, we first constructed a screening test
that was based on between-family information and was robust to
Table 3. Type I error rates (in percentage) of the five tests based on simulation set 3.
m=1 m=2
S L Joint FTSA AFTSA Tscreen TAscreen Joint FTSA AFTSA Tscreen TAscreen
400 200 4.1 2.9 3.3 5.5 5.31204 4.2 3.6 3.6 7.0 6.06805
400 3.8 4 4.5 5.5 5.17645 4.2 3.8 3.8 7.0 5.56551
800 3.4 3.8 3.3 5.5 5.01086 4.2 3.8 3.5 7.0 5.01277
600 200 4.4 3.2 3.8 5.8 5.34633 6.5 4.7 4.7 8.1 6.37518
400 4.7 4.1 2.9 5.8 5.23698 6.5 5.3 2.9 8.1 5.75471
800 2.9 4.1 2.8 5.8 5.00985 4.1 7.1 3.5 8.1 5.01071
800 200 3.5 3.8 4.2 6.0 5.48167 5.9 5 5.4 9.1 6.85698
400 3.7 4.2 3.4 5.7 5.30941 5.0 6.6 4.4 8.7 6.01961
800 3.3 3.6 3 6.1 5.01124 5 5.1 4.4 9.1 5.01138
Significant level is 5%.
Note: S denotes sample size in trios; L denotes the number of genomic markers used to control population stratification.
doi:10.1371/journal.pone.0021957.t003
Figure 1. Power comparison under simulation set 1 when m=2.In the first row, we compare power of the three methods for different values
of heritability under the three disease models while sample size is 600 trios and the number of markers selected at the first stage is 10. In the second
row, we compare power of the three methods for different numbers of markers selected at the first stage under the three disease models while
sample size is 600 trios and heritability is 0.05. In the third row, we compare power of the three methods for different sample sizes under the three
disease models while heritability is 0.05 and the number of markers selected at the first stage is 10. In each case, we use 800 genomic markers to
control for population stratification in the admixture screening test.
doi:10.1371/journal.pone.0021957.g001
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test to select markers. In the second stage, we did joint analysis i.e.
used a test that was a combination of the screening test and the
association test to test association at the selected markers. The joint
analysis was robust to population stratification because both the
screening test and the association test are robust to population
stratification. Our simulation studies showed that the joint analysis
was consistently more powerful than two-stage approaches in
which the association test used in the second stage was only based
on within-family information.
Although we have discussed the joint analysis, in which we only
tested the selected markers in the second stage, it is straightforward
to extend the joint analysis to the p-value weighting scheme
[32,33] in which, instead of testing selected markers only, all
markers are tested in the second stage and the resulting p-values
are weighted using the p-values of the screening test. Using the p-
value weighting scheme, the following steps can be used to
perform the joint analysis. (1) Test all SNPs using the admixture
screening test TAscreen and order SNPs according to their p-values
of the test. (2) Divide the SNPs into groups with the first group
Figure 2. Power comparison under simulation set 2 when sample size is 600 trios. In the first row, we compare power of the three
methods for different values of heritability under the three disease models while m=2 and the number of markers selected at the first stage is 10. In
the second row, we compare power of the three methods for different numbers of markers selected at the first stage under the three disease models
while m=2 and heritability is 0.05. In the third row, we compare power of the three methods for different values of m under the three disease models
while heritability is 0.05 and the number of markers selected at the first stage is 10. In each case, we use 800 genomic markers to control for
population stratification in the admixture screening test.
doi:10.1371/journal.pone.0021957.g002
Figure 3. Power comparison under simulation set 3 when sample size is 600 trios. In the first row, we compare power of the three
methods for different values of heritability under the three disease models while m=2and the number of markers selected at the first stage is 10. In
the second row, we compare power of the three methods for different numbers of markers selected at the first stage under the three disease models
while m=2and heritability is 0.05. In the third row, we compare power of the three methods for different values of m under the three disease models
while heritability is 0.05 and the number of markers selected at the first stage is 10. In each case, we use 800 genomic markers to control for
population stratification in the admixture screening test.
doi:10.1371/journal.pone.0021957.g003
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SNPs. (3) Let ps
ij denote the p-value of the admixture screening test
at the jth SNP in the ith group and pij~1=ps
ij: Define an
importance measure Iij~pij=pi and a weight wij~Iij= 2iki ðÞ for
the jth SNP in the ith group, where pi~ pi1z...zpiki ðÞ =ki (4)
Test each SNP using the joint test statistic Tjoint~TAscreenzTa:
Denote pij the p-value of the joint test at the jth SNP in the ith
group. Then, declare the jth SNP in the ith group to be significant
at a level of a if pijƒawj: For the method of Ionita-Laza et al [32],
Iij~1 Furthermore, for simplicity, we discussed our method using
nuclear families. Our method can be also applied to general
pedigrees. In fact, both the screening test Tscreen given by equation
(1) and association test Ta given by equation (3) are applicable to
general pedigrees [27,28].
It should be noted that the PC approach used in TAscreen to
control for population stratification may be not as strongly
resistant to stratification bias as the approach in Steen et al. [7]
in which the significant association totally depends on the family-
based association test used in the second stage. Other problems of
the PC approach include (1) there is no standard as to how many
PCs should be used; (2) the PC approach uses additive coding to
code the population structure and also assumes additivity between
the effects of the PCs and the effects of the genomic markers.
According to our experience of using the PC approach, however, if
we use all markers in a GWAS as genomic markers, the first 10
PCs can capture subtle population structures such as the
population structure in European Americans.
One remaining question is choosing the value of R, the number
of markers selected in the first stage. Although there is no unique
answer in choosing an optimal value of R, our simulations indicate
that 10 is a good choice of R which is consistent with the results of
Steen et al [7]. However, we need further investigations on
choosing the optimal value of R in general.
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